Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 Diabetes
People with type 2 diabetes (T2D) have increased risks of macrovascular and microvascular complications, which lead to an escalated risk of premature death. Compared with people without T2D at the age of 50, having T2D is associated with a life expectancy (LE) loss of 6 years. However, studies show that adults with diabetes type 2 can prolong their life expectancy if they are able to regulate their blood pressure, glucose and cholesterol levels, and body weight. Better control of blood pressure, glucose and cholesterol levels, and body weight in people with T2D can potentially reduce the risk of diabetes-related complications and mortality, thus extending LE. Quantifying life-years gained from better diabetes care is imperative in clinical practice and designing public health interventions. Clinicians can use this information in the shared decision-making process with their patients, emphasizing the benefit of diabetes care in prolonging life expectancy.
Author:
Moises Arjona
Resource Date:
April 18, 2022
Resource Type:
Topics: